Author: admin

Biosurgery Market worth $16.0 Billion by 2026 – Exclusive Report by MarketsandMarkets™

“The Asia Pacific market is expected to grow at the highest CAGR from 2021 to 2026. This can be attributed to the presence of high-growth markets such as India, China, and Japan; rapid growth in the geriatric population; the implementation of favorable government initiatives; growing per capita income; increasing investments in the healthcare industry; the rising demand for cutting-edge technologies; and the expansion of private-sector hospitals to rural areas.”
The prominent players in this biosurgery market are Johnson & Johnson (US), Baxter International Inc. (US), Medtronic Plc (Ireland), Becton, Dickinson & Co. (US)

According to the new market research report “Biosurgery Market by Product Type (Sealants, Hemostats, Adhesion Barrier, Soft Tissue Attachments, Biological Meshes, DBM, Bone Graft Substitutes), Application (Orthopedic, Cardiovascular), End User (Hospitals, Clinics) – Global Forecast to 2026″, published by MarketsandMarkets™, the Biosurgery Market is projected to reach USD 16.0 billion by 2026 from USD 12.2 billion in 2021, at a CAGR of 5.7% during the forecast period.

Browse in-depth TOC on “Biosurgery Market”

439 – Tables

52 – Figures

392 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166922302

A significant rise in the number of surgical procedures across the globe is driving the demand for biosurgery products. The increase in the number of elective surgeries can be attributed to the growing prevalence of obesity and other lifestyle diseases, the rising geriatric population, the increasing prevalence of orthopedic conditions, and the increasing incidence of spinal injuries and sports-related injuries. Biosurgery products are finding substantial application in severe trauma injuries, including traumatic brain injuries (TBIs), spinal cord injuries, spine fractures, collapsed lungs, and subarachnoid hemorrhage. Additionally, rising focus towards effective blood loss management during surgeries are also supporting the demand for biosurgery products such as hemostatic agents and surgical sealants and adhesives. Moreover, established market players are investing heavily into product R&D to gain competitive edge, which has resulted into an increasing availability of advanced biosurgery products in the market.

On the other hand, high cost of biosurgery product is one of the restraining factor to the biosurgery market growth. Most of the products available in this market are priced at a premium. The high cost, coupled with the unfavorable reimbursement scenario for these products in several emerging countries, makes them unaffordable for a large section of the target patient population. Moreover, the dearth of skilled professionals and stringent regulations are further expected to hamper the growth of this market during the forecast period.

The surgical sealants and adhesives segment is expected to grow at the highest CAGR during the forecast period

Based on the product, the surgical sealants and adhesives segment accounted to be the fastest-growing segment in the global biosurgery market in 2020. Sealants and adhesives have successfully replaced traditional wound closure techniques, such as suturing or stapling, in many surgical applications. These products are becoming an increasingly important element in modern medicine by enabling innate wound healing processes to occur through the adhesion of tissue to the on-site or non-tissue surfaces. The high growth of surgical sealants and adhesives segment can be attributed to the growing adoption of natural/biological sealants such as fibrin-based sealants globally, owing to their relative safety and low risk of infection.

The orthopedic segment accounted for the largest share of the biosurgery market, by application

Based on applications, the orthopedic segment commanded the largest share in 2020. Increasing incidence of sports injuries and the growing prevalence of lifestyle disorders, such as arthritis, osteoporosis, and obesity (leading to orthopedic problems), have surged the volume of orthopedic surgeries. Orthopedic surgical procedures are often associated with the risk of significant blood loss owing to the dissection of bony and fibrotic tissues. Thus, bleeding management and the effective regeneration of tissues and bones are the common challenges faced by orthopedic surgeons. In order to overcome these challenges, surgeons finds substantial use of surgical sealants, hemostats, bone-graft substitutes, and soft-tissue repair products, which is driving the revenue growth in the segment.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=166922302

Hospitals segment accounted for the largest share of the market, by end user

The biosurgery market, by end-user, is segmented into hospitals, clinics, and others. The hospital segment accounted for the largest market share in 2020. The large share of this segment can be attributed to the rising number of hospitals and infrastructural & economic development, especially in emerging countries. Additionally, the rising surgical procedures performed across operating rooms—where biosurgery products are substantially used across various surgical procedures—also supports high growth in the hospitals segment.

Asia Pacific is expected to show the highest growth rate in the biosurgery market

The Asia Pacific market is expected to grow at the highest CAGR from 2021 to 2026. This can be attributed to the presence of high-growth markets such as India, China, and Japan; rapid growth in the geriatric population; the implementation of favorable government initiatives; growing per capita income; increasing investments in the healthcare industry; the rising demand for cutting-edge technologies; and the expansion of private-sector hospitals to rural areas. In addition, the Asia Pacific is becoming a medical tourism hub and is considered one of the fastest-growing markets for surgical products. Low infrastructure and treatment costs and the availability of highly educated physicians have driven medical tourists to APAC countries, particularly to India and China.

The prominent players in this biosurgery market are Johnson & Johnson (US), Baxter International Inc. (US), Medtronic Plc (Ireland), Becton, Dickinson & Co. (US), B. Braun Melsungen AG (Germany), Stryker Corp. (US), Integra Lifesciences Holdings Corp. (US), CSL Ltd. (Australia), Hemostasis LLC. (US), Pfizer Inc. (US), Cyrolife Inc. (US), Zimmer Biomet (US), Kuros Biosciences AG (Switzerland), Orthofix Medical Inc. (US), and Smiths & Nephew Plc. (UK).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=166922302

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/biosurgery-market-166922302.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Biosurgery Market worth $16.0 Billion by 2026 – Exclusive Report by MarketsandMarkets™

The Center for the Multidisciplinary Study of Cybernetic Existentialism Announces Exhibition Honoring Ruffo Caselli’s Robotics-Inspired Artwork

Nizhny Tagil Art Museum Hosts Retrospective Featuring Caselli’s Pioneering Contributions to Contemporary Art Until March 3.

In Russia, the Nizhny Tagil Art Museum has inaugurated an exhibition dedicated to the pioneering art of the founder of Cybernetic Existentialism Ruffo Caselli (Florence 1932-Ovada 2020), known for his contributions to contemporary art and his poetic and prophetic interpretation of robotics. The exhibit will be open until March 3, 2025.



The elegant humanoid robots painted on canvasses on display captivated the Russian public. This significant event attracted a large crowd of journalists and art scholars eager to delve deeper into Caselli’s unique vision and legacy. The brilliant opening conference was led by Elena Garas, esteemed scholar of contemporary art and long-time supporter of Caselli’s profound impact. His works have been highly appreciated in Russia, having been previously exhibited in prestigious cultural centers such as the Historical Chelyabinsk Urals Museum and the Uray Museum in the Khanty-Mansiysk Autonomous District.

The inauguration was completed by remarks from the director of the Museum, Marina Vladivorovna Ageeva, and the museum curator, Olga Victorovna Lebedeva.

After numerous exhibitions in his hometown of Milan, Ruffo Caselli’s works gained a favorable public reception in the United States in 1980, following exhibitions at the prestigious Carmen Gallo’s gallery in Manhattan, which sponsored his unique style and promoted exhibitions not only in the United States, but also in South America, Dubai, and Korea.

Giusi Gallo, a personal friend of the painter and passionate about contemporary art, states:

“Ruffo Caselli’s art, in my opinion, can be interpreted in an evolutionary way. According to modern theory, there are six Kingdoms in nature. I would define the “seventh Kingdom” as the one created by man: the robot. These six Kingdoms are all essential for the functioning of the “Earth ecosystem”. The basis of all living beings is the cell, and the basis of robots are microchips. Robots are a major technological innovation that provides a complete technical apparatus capable of providing quick answers. The machine carries out orders and is now fundamental in many sectors, from medicine to production, research, art, and communication. We communicate with the “machine” and it processes the data, but it evolves very quickly, perhaps too quickly, and this could potentially pose a great risk. Ruffo Caselli understood this many years ago.”

For more information on The Center for The Multidisciplinary Study Of Cybernetic Existentialism visit https://www.cyberneticexistentialism.com.

Media Contact
Company Name: Cybernetic Existentialism
Contact Person: Electra Rodham
Email: Send Email
Country: Italy
Website: https://www.cyberneticexistentialism.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: The Center for the Multidisciplinary Study of Cybernetic Existentialism Announces Exhibition Honoring Ruffo Caselli’s Robotics-Inspired Artwork

Digital Business Card Unveils Expert Tips for Making a Lasting Impression at Next Event

Professional events are a chance to build connections, find potential collaborators and learn from peers. To get the most out of these events, it’s helpful to have a clear approach that communicates you and your professional goals. Here are a few tips to make a positive lasting impression at your next event.

1. Plan Your Purpose and Outcomes

Attending any professional event is more productive when you have a clear idea of what you want to achieve. Write down what you hope to get out of it, whether that’s to meet specific people, explore new professional opportunities or learn from industry experts. Having these outcomes in mind before the event will guide your conversations and help you work out how to use your time. It will also give you a framework to evaluate the event afterwards. By knowing what you want to get, you can approach people and topics with purpose and that often leads to more focused conversations and follow up opportunities.

2. Craft Your Elevator Pitch

An elevator pitch is a way to share who you are, what you do and why it matters. Having a few sentences prepared in advance will remove the uncertainty when you meet someone new. You might want to create different versions of this pitch for different contexts – one for your technical role and one for the broader impact of your work. Practice each version with a friend or colleague to get feedback on clarity and delivery. You can also tailor your pitch on the spot by adding in details that are relevant to the person you are speaking with. A well prepared pitch will set a confident and organized tone for the rest of the conversation.

3. Body Language

Body language speaks louder than words. Simple actions like making eye contact, sitting relaxed and nodding slightly to show you’re engaged can make others feel comfortable when talking to you. If you notice signs of tension – raised shoulders or crossed arms – take a moment to relax as openness makes conversations more inviting. Also mirror the speaking pace of the person you’re talking to when you can. This is called “synchronizing” and can create a sense of understanding. By being aware of these non verbal cues you’re sending a message of respect and interest.

4. Swap Information Easily

Sharing contact details is a common practice at events but there are many ways to do it. Traditional paper business cards still have their place but consider offering a digital alternative to stand out. Handing over a Digital Business Card is a simple yet powerful way to make a lasting impression. This takes only a moment as you can send your details via a smartphone or share a secure link. Recipients can store the information instantly so you don’t lose physical cards. Plus digital cards can highlight your branding, specialties or portfolio links in a neat format so contacts can remember who you are and why they found you interesting.

5. Have a Real Conversation

Many professionals attend events to build long term relationships and authentic conversation is the foundation of these relationships. Ask questions that go beyond “What do you do?” and show genuine interest in the projects or challenges your conversation partner is facing. Active listening techniques like summarizing key points or asking follow up questions show you value their input. When appropriate you can naturally weave in details about your own background, experiences or ambitions. This exchange of information can lead to a deeper understanding of shared professional interests and open up opportunities for partnerships or referrals.

6. Follow Up Thoughtfully

After the event the next step is to keep the relationships alive. Send a personal note or a brief message on a professional platform so others remember who you are and how you met. If you discussed specific topics you may want to reference them in your message to show you were paying attention. You could even suggest a virtual or in-person meeting to continue the conversation in more detail. By being intentional about follow up you’re showing you’re interested in a future relationship. This is especially useful if you’re open to collaborative projects or mutual introductions so the value of the event extends beyond the event itself.

By being clear, confident and authentic you can make an impact at any professional event. Having a short elevator pitch, relaxed body language and a way to swap information are the ways to stand out. As events change, consider adding digital business cards to the mix so your details are always to hand and memorable.

Media Contact
Company Name: Digital Business Card
Contact Person: Mike Hassy
Email: Send Email
City: New York
Country: United States
Website: https://www.digitalbusinesscard.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Digital Business Card Unveils Expert Tips for Making a Lasting Impression at Next Event

CollabWorkx Launches Revolutionary 2.0 Platform to Transform Workplace Collaboration

Virginia Beach, Virginia – CollabWorkx, a cutting-edge work management platform, today announced the launch of its highly anticipated CollabWorkx 2.0, redefining workplace collaboration for businesses of all sizes.

This next-generation platform seamlessly integrates communication, collaboration, project management, task tracking, and meeting tools into one unified solution, empowering organizations to operate with unparalleled efficiency and scalability. CollabWorkx 2.0 is built on a federated network, offering businesses the flexibility to unite multiple teams, partners, and locations in a secure and cohesive virtual environment.

Available on both cloud and on-premise setups, the platform caters to the unique needs of hybrid and remote workforces. “We’re thrilled to unveil CollabWorkx 2.0,” said Bevon Moore, Founder and CEO.

Video Link: https://www.youtube.com/embed/9UCNwC42_qI

“This milestone reflects our commitment to delivering a solution that not only addresses the challenges of modern workplaces but also empowers teams to achieve their goals securely and efficiently. With CollabWorkx, collaboration knows no boundaries.” Key Features of CollabWorkx 2.0 Include: Unified Collaboration: All-in-one platform for seamless communication, project management, and task tracking.

Federated Collaboration Network: Connect multiple networks, locations, and partners for secure, cross-organizational teamwork. Scalability & Flexibility: Start with everything you need and scale as your business grows.

Enhanced Security: Robust data protection features to safeguard sensitive information. Mobile Apps: Stay connected on-the-go with apps available on the Apple App Store and Google Play Store. To date, CollabWorkx serves over 24,000 businesses worldwide.

The platform remains committed to offering its core features at no cost, making innovative workplace tools accessible to all. Availability CollabWorkx 2.0 is now available with early access for select users and will be officially launched to the public on 1/21/2025.

For more information, visit www.collabworkx.com or contact: Jordan@collabworkx.com

Media Contact
Company Name: CollabWorkx
Email: Send Email
Country: United States
Website: www.collabworkx.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: CollabWorkx Launches Revolutionary 2.0 Platform to Transform Workplace Collaboration

Microplate Systems Market worth $1170 million by 2026

“Danaher Corporation (US) held the leading position in the microplate systems market. The company offers an exhaustive product portfolio consisting of various microplate systems products.”
Microplate Systems Market by Product (Microplate Reader (Multi-mode, Single-mode), Microplate Washer, Microplate Accessories), Application (Drug Discovery, Clinical Diagnostics) & End User (Hospital and Diagnostic Laboratories) – Global Forecast to 2026

The report “Microplate Systems Marketby Product (Microplate Reader (Multi-mode, Single-mode), Microplate Washer, Microplate Accessories), Application (Drug Discovery, Clinical Diagnostics) & End User (Hospital and Diagnostic Laboratories) – Global Forecast to 2026″, The global microplate systems market size is projected to reach USD 1,170 million by 2026 from USD 927 million in 2021, at a CAGR of 4.8%.

Download Report Brochure @https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=37081572

The growth in this market is attributed to the increasing R&D expenditure in the pharmaceutical industry, increasing focus on miniaturization and the growing prevalence of disease.

Key Market Players

The microplate systems market is highly consolidated and is dominated by various players. The major players operating in this market are Bio-Rad Laboratories Inc. (US), PerkinElmer (US), Danaher Corporation (US), Thermo Fisher Scientific (US), Agilent Technologies Inc. (US), Tecan (Switzerland), BMG Labtech (Germany), Promega Corporation (US), Enzo Life Sciences Inc. (US), Berthold Technologies (Germany), Biochrom (UK), Corning (US), Lonza (Switzerland), Brucker Corporation (US), Dynex Technologies (US), Bio-One International GmbH (Austria), Accuris Instruments (US), CTK Biotech Inc. (US), LTEK (South Korea), JASCO (Japan), Rayto (China), Micro Lab Instruments (India), Biohit Oyj (Finland), Mindray (China), and Hudson Robotics (US).

DRIVER: Increasing R&D expenditure in the biopharmaceutical company

The pharmaceutical and biotechnology industries are among the major end users in the microplate systems market. Microplate systems find high use in modern drug discovery and development activities and genomic & proteomic research, as they increase the test speed and accuracy, thus saving time and enabling researchers to focus on core tasks. Consequently, the increasing pace of R&D in the pharmaceutical industry as evidenced by the rising expenditure in this area can be taken as a key growth driver for the market.

According to PhRMA, the R&D expenditure of PhRMA member companies in the US increased from ~USD 26.0 billion in 2000 to USD 58.8 billion in 2015. In Europe, the pharmaceutical R&D expenditure increased from USD 16.5 billion (EUR 17.8 billion) in 2000 to USD 45.6 billion (EUR 37.5 billion)

OPPORTUNITY: Growth in the pharmaceutical and biotechnology industries

In the last decade, the number of pharma companies has grown significantly, especially in the emerging markets. As of 2019, there are 1,131 publicly listed pharmaceutical and biotech companies across the Asia Pacific, indicating a significant presence of local as well as international players in the region.

According to the Pharmaceutical Research and Manufacturers Association (PhRMA), US firms conduct a majority of the world’s R&D in pharmaceuticals and hold the intellectual property rights to most new medicines. In addition, the biopharmaceutical industry has developed over 5,000 new medicines around the world, with ~3,400 compounds currently being studied in the US–more than in any other region around the world.

Request Free Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=37081572

Microplate readers accounted for the larger share of the Microplate Systems Market

Based on the product, the microplate systems market is segmented into microplate readers, microplate pipetting systems and dispensers, microplate washers, and microplate accessories & software. In 2020, the microplate readers segment accounted for the larger share of the microplate systems market. The large share of this segment can be attributed to the increasing prevalence of diseases, the growing focus on drug discovery, and the rising R&D expenditure by pharmaceutical companies.

By application, the drug discovery segment accounted for the largest market share

Based on the application, the microplate systems market is segmented into drug discovery, clinical diagnostics, genomics and proteomics research, and other applications. The drug discovery segment accounted for the largest market share in 2020. The need for high-/ultra-high-throughput screening and reduced time-to-market for drugs are major driving factors for this market.

Biotechnology & Pharmaceutical are the largest end-users of the microplate systems market

Based on end-users, the microplate systems market is segmented into biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and academic & research institutes. The biotechnology & pharmaceutical segment accounted for the largest market share in 2020 due to increasing government support in the form of funding for biotech and pharma research.

Inquiry Before Buying @https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=37081572

North America dominates the global microplate systems market

The microplate systems market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest share of the microplate systems market. The large share of North America can be attributed to factors such as the government initiatives for cell-based research, the increasing acceptance of personalized medicine, increasing academic and government investments in diagnostic research, and increasing focus on drug discovery and development.

Scope of the Reports:

Application:

  • Drug Discovery
  • Clinical Diagnostics
  • Genomics and Proteomics Research
  • Other Applications

Recent Developments:

  • Agilent Technologies Inc. launched the BenchCel Microplate Handler
  • Agilent Technologies Inc. acquired BioTek Instruments to strengthen its product portfolio

View detailed Table of Content here @https://www.marketsandmarkets.com/Market-Reports/microplate-systems-market-37081572.html

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/microplate-systems-market-37081572.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Microplate Systems Market worth $1170 million by 2026

Specialty Carbon Black Market Growth Report: $3.03 Bn Revenue by 2029 – Arizton

“Specialty Carbon Black Market Research Report by Arizton”

 

According to Arizton’s latest research report, the specialty carbon black market is growing at a CAGR of 5.06% during 2023-2029.

        

To Know More, Click: https://www.arizton.com/market-reports/specialty-carbon-black-market

 

Report Summary         

Market Size (2029): $3.03 Billion   

Market Size (2023): $2.25 Billion  

CAGR (2023-2029): 5.06%   

Market Size – Volume (2029):1,518.67 Kilotons

Historic Year: 2020-2022  

Base Year: 2023  

Forecast Year: 2024-2029  

Market Segmentation: Grade Type, Formulation, Process, Application, End-Users, and Geography

Geographic Analysis: North America, Europe, APAC, Latin America, and Middle East & Africa

  

Specialty Carbon Black Market Overview

The global specialty carbon black market is experiencing significant growth due to its versatile applications across various industries, including plastics, paints, coatings, inks, and battery technologies. It is widely used as a pigment, UV stabilizer, and conductivity enhancer, particularly in plastics, where it is crucial for providing consistent color, UV protection, and environmental stability. The growing demand for high-performance materials, especially in automotive, packaging, and consumer goods, is driving the need for specialty carbon black, which enhances the durability and performance of plastic products. Additionally, the material’s use in paints, coatings, and battery electrodes further supports market growth, particularly in regions like APAC, where industrialization and the rise of electric vehicles are increasing demand.

However, the market faces challenges, including stringent environmental regulations, such as the EU’s Industrial Emissions Directive, which imposes limits on emissions from carbon black production. These regulations increase operational costs and complexity. Furthermore, raw material price volatility, particularly fluctuations in crude oil prices, adds uncertainty to production costs. Despite these obstacles, the specialty carbon black market is poised for continued expansion, driven by the increasing demand for high-quality materials in automotive, electronics, and construction, along with the growing focus on sustainable energy and green technologies in developing regions like APAC.

 

Automotive Growth and Infrastructure Development Fuel Specialty Carbon Black Market in APAC

The specialty carbon black market in APAC is expected to experience significant growth due to increasing residential construction and urbanization. As GDP per capita rises and infrastructure develops, rural areas are transitioning into urban regions, boosting retail sales and industrial growth. The construction industry is set to expand, with urban households in the region projected to increase by 68% from 2010 to 2030. This urbanization, along with growth in the automotive sector, is driving the demand for specialty carbon black, especially in coatings. The rising vehicle production and sales in India, China, and Japan are fueling the need for protective coatings, which enhance aesthetics, corrosion resistance, and durability. APAC’s automotive growth, supported by a skilled workforce, competitive costs, and strong infrastructure, is positioning specialty carbon black as a key material for performance-driven components. Economic growth and rising car sales are further boosting the demand for specialty carbon black in the region.

 

The Global Paints & Coatings Specialty Carbon Black Market to Reach $585.94 Million by 2029

Specialty carbon black plays a crucial role in the paints and coatings industry, serving as a pigment and reinforcing agent. It enhances color intensity, provides UV protection, and improves durability, making it the preferred choice for a wide range of applications, from automotive to industrial coatings. In decorative coatings, it offers deep black hues and resistance to fading, chalking, and cracking, while improving mechanical properties such as scratch, abrasion, and impact resistance. This makes it indispensable for coatings in challenging environments, including automotive, aerospace, and heavy machinery sectors. The growing demand for high-performance coatings, particularly in the automotive industry with the rise of electric vehicles, is driving market growth. Companies like Cabot are advancing carbon black technology to meet industry needs, further fueling expansion. As industries seek longer-lasting, durable coatings, the demand for specialty carbon black is expected to continue rising, creating opportunities for innovation and market growth.

 

Competitive Landscape and Strategic Initiatives in the Specialty Carbon Black Market

The specialty carbon black market is highly competitive, with key players such as Cabot Corporation, Orion Engineered Carbons, Birla Carbon, and Phillips Carbon Black Ltd. employing strategies like capacity expansions, product innovation, and sustainability initiatives to strengthen their market positions. Major trends driving the market include the adoption of carbon black in lithium-ion batteries for electric vehicles (EVs), growing demand in automotive, plastics, and coatings industries, and a strong focus on sustainability. Companies are increasingly exploring alternative raw materials and eco-friendly production methods to meet environmental regulations. For example, Phillips Carbon Black invested in enhancing production capabilities and R&D, while Orion Engineered Carbons introduced new carbon black grades for high-performance applications.

Strategic initiatives, such as mergers, acquisitions, and partnerships, are also key for expanding market presence and technological capabilities. Birla Carbon’s partnership with Circtec focuses on sustainable carbon black derived from end-of-life tires. As the market evolves, innovation, sustainability, and strategic expansions remain essential for long-term growth. Companies that prioritize eco-friendly practices, advanced research, and product diversification are well-positioned to meet the increasing demand and stay competitive.

 

Recent Developments in the Global Specialty Carbon Black Market

  • In 2024, Himadri Speciality Chemical Ltd revealed plans to invest USD 2.64 billion to expand its specialty carbon black production capacity in Singur, West Bengal. This expansion, set to be completed within 18 months, will increase the company’s annual output by 70,000 tonnes, raising total capacity from 180,000 to 250,000 tonnes, in response to rising European demand, driven by the impending EU ban on Russian imports.
  • Also in 2024, Birla Carbon announced Greenfield expansions in the APAC region, with plans to increase its carbon black capacity by over 240 kilotons across locations in India and Thailand.
  • In 2023, Orion S.A. launched its first circular specialty carbon black for polymers at the 2023 Compounding World Expo North America in Cleveland, alongside carbon blacks designed to enhance rheology, UV resistance, and conductivity.
  • Additionally, in 2023, Orion Engineered Carbons partnered with Ion Specialties to enhance its presence in the Mexican market, leveraging Ion Specialties’ established infrastructure, including warehouses, laboratories, and logistical support.

 

Buy this Research @ https://www.arizton.com/market-reports/specialty-carbon-black-market

    

Key Company Profiles

  • Aditya Birla Group
  • Cabot Corporation
  • Orion S.A.
  • Himadri Specialty Chemical Ltd.
  • PCBL Chemical Limited
  • Black Bear Carbon
  • Continental Carbon Company
  • Jiangxi Black Cat Carbon Black Inc., Ltd
  • Omsk Carbon Group
  • Imerys Graphite & Carbon
  • OCI Company Ltd.
  • Denka Company Limited
  • Akrochem Corporation
  • Mitsubishi Chemical Group Corporation
  • Ralson Carbon
  • PentaCarbon
  • Beilum Carbon Chemical Limited
  • M J Pigment & Additives
  • ADL NRG GmbH
  • Lehmann & Voss & Co.

 

Market Segmentation

 

Grade Type

  • Standard
  • High
  • Ultra High

 

Formulation

  • Granule
  • Powder
  • Other Forms

 

Process

  • Furnace Black
  • Gas Black
  • Acetylene Black
  • Thermal Black
  • Other Processes

 

Application

  • Polymers
  • Ink & Toners
  • Paints & Coatings
  • Battery & Storages
  • Other Applications

 

End-Users

  • Automotive
  • Printing & Packaging
  • Construction
  • Electric & Electronics
  • Wind Energy
  • Other Users

 

Geography

 

APAC

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand

 

North America

  • The U.S.
  • Canada

 

Europe

  • Germany
  • The U.K.
  • France
  • Italy
  • Spain
  • Sweden

 

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Chile

 

Middle East & Africa

  • The UAE
  • South Africa
  • Saudi Arabia
  • Turkey

 

Key Questions Answered in the Report:        

How big is the global specialty carbon black market?

What is the growth rate of the global specialty carbon black market?

Which region dominates the global specialty carbon black market share?

Who are the key players in the global specialty carbon black market?

What are the significant trends in the specialty carbon black market?

   

Check Out Some of the Top Selling Reports of Your Interest:     

Specialty Chemicals Market – Global Outlook and Forecast 2024-2029

https://www.arizton.com/market-reports/specialty-chemicals-market-size

Industrial Wax Market – Global Outlook & Forecast 2024-2029

https://www.arizton.com/market-reports/industrial-wax-market

   

Why Arizton?                                       

100% Customer Satisfaction                                       

24×7 availability – we are always there when you need us                                       

200+ Fortune 500 Companies trust Arizton’s report                                       

80% of our reports are exclusive and first in the industry                                       

100% more data and analysis                                       

1500+ reports published till date                     

        

Post-Purchase Benefit                                   

  • 1hr of free analyst discussion                                   
  • 10% off on customization                

        

About Us:                                                                            

Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                                          

We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                                           

Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                                                 

Media Contact
Company Name: Arizton Advisory & Intelligence
Contact Person: Jessica
Email: Send Email
Phone: +1 3122332770
Country: United States
Website: https://www.arizton.com/market-reports/specialty-carbon-black-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Specialty Carbon Black Market Growth Report: $3.03 Bn Revenue by 2029 – Arizton

Developmental and Epileptic Encephalopathy Therapeutics Market Size was ~USD 2,100 Million in 2023, it is expected to grow with a significant CAGR by 2034 | DelveInsight

DelveInsight’s “Developmental and Epileptic Encephalopathy Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of DEE, historical and forecasted epidemiology as well as DEE market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

 

Unlock key insights into the Developmental and Epileptic Encephalopathies Market! Download DelveInsight’s comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Developmental and Epileptic Encephalopathies Market Size

 

Key Takeaways from the Developmental and Epileptic Encephalopathies Market Report

  • In December 2024:- Longboard Pharmaceuticals- The objective of this study is to assess the long-term safety, tolerability, and efficacy of adjunctive therapy of LP352 in subjects with developmental and epileptic encephalopathies who completed participation in Study LP352-201.
  • The total number of diagnosed prevalent cases of DEE in the 7MM was nearly 284,000 cases in 2023 and are projected to increase during the forecasted period.
  • Lennox-Gastaut syndrome (LGS) and Tuberous sclerosis complex (TSC) asscociated epilepsy are the largest contributors to the overall DEE pool. The prevalent cases of DEE in the United States were nearly 50,000 for LGS and nearly 47,100 for TSC with epilepsy in 2023.
  • The total number of cases in EU4 and the UK for DEE was estimated to be nearly 104,000 cases in 2023.
  • Among EU4 and the UK, the highest number of cases for DEE was found in Germany which was estimated to nearly 34% of cases in EU4 and the UK in 2023.
  • The total number of cases in Japan for DEE was estimated to be nearly 34,000 cases in 2023.
  • The leading Developmental and Epileptic Encephalopathies Companies such as Jazz Pharmaceuticals, Biocodex, Zogenix (Acquired by UCB), Lundbeck, Marinus Pharmaceuticals, Novartis, Aquestive Therapeutics, Supernus Pharmaceuticals, Lundbeck, Eisai Pharmaceuticals, GlaxoSmithKline, Meda Pharmaceuticals, Roche, Questcor Pharmaceuticals/Mallinckrodt Pharmaceuticals, Xenon Pharmaceuticals, Takeda/Ovid Therapeutics, SK Life Science, Epygenix, Neurocrine Biosciences, Stoke Therapeutics, Neurocrine Biosciences, BioPharm Solutions, Praxis Precision Medicines, Epygenix, Longboard Pharmaceuticals, and others.
  • Promising Developmental and Epileptic Encephalopathies Therapies such as LP352, Bexicaserin, Soticlestat, and others.

 

Stay ahead in the competitive landscape of the Developmental and Epileptic Encephalopathies Market. Access DelveInsight’s in-depth market analysis and strategic insights today! Click here for more @ Developmental and Epileptic Encephalopathies Treatment Market Size

 

Developmental and Epileptic Encephalopathies Epidemiology Segmentation in the 7MM

  • Total Developmental and Epileptic Encephalopathies Diagnosed Prevalent Cases
  • Developmental and Epileptic Encephalopathies Cases by Subtypes

 

Download the report to understand which factors are driving Developmental and Epileptic Encephalopathies epidemiology trends @ Developmental and Epileptic Encephalopathies Prevalence

 

Developmental and Epileptic Encephalopathies Marketed Drugs

  • EPIDIOLEX (cannabidiol): Jazz Pharmaceuticals

EPIDIOLEX, also known as EPIDYOLEX in Europe, is the first prescription, plant-derived cannabis oral formulation developed by GW Pharmaceuticals. It is a novel class of antiepileptic medications with a different mechanism of action. The drug is the first FDA-approved drug that contains a purified drug substance derived from marijuana, and the active ingredient is cannabidiol (CBD). Under the Controlled Substances Act (CSA), CBD is classified as a Schedule I substance; thus, GW Pharmaceuticals conducted nonclinical and clinical studies to assess the abuse potential of CBD to support its usage.

 

  • FINTEPLA (fenfluramine): UCB

FINTEPLA (formerly known as ZX008) is an oral medication that is a low-dose solution of fenfluramine hydrochloride. It prevents the entry of calcium ions into nerve cells, lowering their over-excitability and reducing seizure episodes. It also activates serotonin receptors, which contribute to the overall antiepileptic action.

 

Developmental and Epileptic Encephalopathies Emerging Drugs

  • Zorevunersen (STK-001): Stoke Therapeutics

Zorevunersen is an investigational new medicine for the treatment of Dravet syndrome. It is a proprietary antisense oligonucleotide (ASO) and has the potential to be the first disease-modifying therapy to address the genetic cause of Dravet syndrome. The drug is designed to upregulate NaV1.1 protein expression by leveraging the non-mutant copy of the SCN1A gene to restore physiological NaV1.1 levels, thereby reducing both occurrences of seizures and significant non-seizure comorbidities.

 

  • Bexicaserin (LP352): Longboard Pharmaceuticals

Bexicaserin is an oral, centrally acting, 5-HT2c superagonist in development for the potential treatment of seizures associated with DEEs such as Dravet syndrome, LGS, tuberous sclerosis complex (TSC), CDKL5 deficiency disorder (CDD), and other epileptic disorders. LP352 is designed to modulate GABA and, as a result, suppress the central hyperexcitability that is characteristic of seizures. LP352 is the only 5-HT2c receptor superagonist being dose-optimized for the refractory epilepsy population.

 

Discover the future of Developmental and Epileptic Encephalopathies treatments with DelveInsight’s latest market report. Get expert insights and forecasts—download now! @ Developmental and Epileptic Encephalopathies Market Drivers and Barriers

 

Developmental and Epileptic Encephalopathies Market Outlook

In recent years, three antiseizure medications have been approved as adjunct therapy in patients with Dravet Syndrome: DIACOMIT (Stiripentol), which was approved in the US in 2018 and received full European marketing authorization in 2014, EPIDIOLEX (cannabidiol) which was approved by the FDA in 2018, and FINTEPLA (fenfluramine), which was approved in 2020 in the US and EU. These treatments are “add-on” therapies (most usually used in conjunction with Valproate and clobazam) with availability and recommendations in various countries influencing the decision in the EU.

 

Developmental and Epileptic Encephalopathies Drugs Market

Disease-modifying therapies represent a significant leap forward in the treatment of Developmental and Epileptic Encephalopathies (DEE). These innovative approaches have the potential to transform the landscape of care, offering new hope to patients and families affected by these challenging conditions. For instance, if approved, STK-001 could become the first disease-modifying medicine for Dravet syndrome, a severe form of epilepsy. This breakthrough would not only address the symptoms but also target the underlying causes of the disease, marking the dawn of a new era in DEE treatment.

 

Explore the dynamics of the Developmental and Epileptic Encephalopathies Market with DelveInsight. From market size to emerging drugs—find it all in our latest report. Read now! @ Developmental and Epileptic Encephalopathies Ongoing Clinical Trials Analysis

 

Scope of the Developmental and Epileptic Encephalopathies Market Report

  • Coverage- 7MM
  • Study Period- 2020-2034
  • Developmental and Epileptic Encephalopathies Companies- Jazz Pharmaceuticals, Biocodex, Zogenix (Acquired by UCB), Lundbeck, Marinus Pharmaceuticals, Novartis, Aquestive Therapeutics, Supernus Pharmaceuticals, Lundbeck, Eisai Pharmaceuticals, GlaxoSmithKline, Meda Pharmaceuticals, Roche, Questcor Pharmaceuticals/Mallinckrodt Pharmaceuticals, Xenon Pharmaceuticals, Takeda/Ovid Therapeutics, SK Life Science, Epygenix, Neurocrine Biosciences, Stoke Therapeutics, Neurocrine Biosciences, BioPharm Solutions, Praxis Precision Medicines, Epygenix, Longboard Pharmaceuticals, and others.
  • Developmental and Epileptic Encephalopathies Therapies- LP352, Bexicaserin, Soticlestat, and others.
  • Developmental and Epileptic Encephalopathies Therapeutic Assessment: Developmental and Epileptic Encephalopathies Current Marketed and Developmental and Epileptic Encephalopathies Emerging Therapies
  • Developmental and Epileptic Encephalopathies Market Dynamics: Developmental and Epileptic Encephalopathies market drivers and Developmental and Epileptic Encephalopathies market barriers
  • Developmental and Epileptic Encephalopathies Unmet Needs, KOL’s views, Analyst’s views, Developmental and Epileptic Encephalopathies Market Access and Reimbursement

 

Table of Content

1. Key Insights

2. Report Introduction

3. Executive Summary

4. DEE Market Overview at a Glance

5. Key Events

6. Epidemiology and Market Methodology

7. Disease Background and Overview

8. Treatment of DEE

9. Epidemiology and Patient Population

10. Patient Journey

11. Marketed Drugs

12. Emerging Drugs

13. DEE: The 7MM Analysis

14. Unmet Needs

15. SWOT Analysis

16. KOL Views

17. Market Access and Reimbursement

18. Appendix

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Developmental and Epileptic Encephalopathy Therapeutics Market Size was ~USD 2,100 Million in 2023, it is expected to grow with a significant CAGR by 2034 | DelveInsight

New Children’s Book “You’re Not Alone” Addresses Bullying Through a Story of Courage and Hope

Author Fouche Francois Jr. Reflects on Childhood Experiences to Empower Young Readers.

Fouche Francois Jr. is pleased to announce the publication of his new children’s book, “You’re Not Alone,” available now in paperback and ebook formats on Amazon. Drawing on his own experiences from the ages of five to twelve, he provides an uplifting and realistic portrayal of what it feels like to be bullied in a new environment. Through the eyes of a young protagonist grappling with cultural change and social challenges, the story illustrates how resilience, honesty, and empathy can help children overcome intimidation and isolation.

“You’re Not Alone” follows seven-year-old Fouche Francois Jr, who, together with his brother, travels from Haiti to the United States to join his parents. The move stirs excitement for Fouche, as he eagerly anticipates his first day of school in an unfamiliar country. However, his optimism is quickly tested when he realizes he is considered an outcast among his peers. On his very first day, he is drawn into conflict, leading his mother to enroll him and his brother in a private school to shield them from further altercations.

The narrative takes a heartfelt turn when Fouche notices another classmate, also deemed an outcast, being targeted by bullies. While he sympathizes and longs to intervene, he is held back by his own fears of becoming the bully’s next victim. The story showcases the emotional complexities children face when confronting hostility, highlighting the balance between wanting to protect others and preserving their own well-being.

In a desperate attempt to keep his tormentor at bay, Fouche pretends to know karate. Although this fabricated skill offers a temporary reprieve, it weighs heavily on him as he struggles with the guilt of deception. He is haunted by the possibility that someone might uncover the truth, which would only intensify the embarrassment he experiences. Ultimately, the momentum of this lie carries him toward a decisive moment when the bully confronts him again, forcing Fouche to prove himself and come to terms with the realities of standing up for what he believes is right.

“I have created a natural and honest account of childhood experiences that I hope will resonate with readers from diverse backgrounds,” commented the author. “The central message of empathy and perseverance underscores how important it is for children to know they are never alone, whether they are facing bullying or navigating other challenges.”

“You’re Not Alone” is designed to help parents, educators, and children gain insight into the emotional effects of bullying while offering a story grounded in understanding and hope. Its emphasis on empathy provides a supportive resource that encourages open dialogue, aiming to spark meaningful conversations about acceptance and unity.

For more information or to order visit https://www.amazon.com/Youre-Not-Alone-Fouche-Francois-ebook/dp/B0DSV4T1D7.

Media Contact
Company Name: Fouche Francois Jr.
Contact Person: Fouche Francois Jr.
Email: Send Email
Country: United States
Website: https://www.amazon.com/Youre-Not-Alone-Fouche-Francois-ebook/dp/B0DSV4T1D7

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: New Children’s Book “You’re Not Alone” Addresses Bullying Through a Story of Courage and Hope

Hydrazine Hydrate Market Forecast 2022-2027: Global Size, Share, and Leading Players Revealed | Arkema S.A. (France), LANXESS AG (Germany), Lonza Group AG (Switzerland) & more

“Browse 246 market data Tables and 49 Figures spread through 226 Pages and in-depth TOC on “Hydrazine Hydrate Market””
The Hydrazine Hydrate market is poised for robust growth, driven by rising demand in water treatment, agrochemicals, and polymer production. With advancements in chemical synthesis and increased industrial applications, the market is set to expand significantly across global regions.

In terms of value, the hydrazine hydrate market is estimated to grow from USD 222 million in 2021 to USD 308 million by 2027, at a CAGR of 5.8%. The report provides a detailed assessment of hydrazine hydrate market growth factors, market definitions, manufacturers, market potential, and influential trends to understand the future demand and outlook for the industry. The research report covers key players in the industry, CAGR values, market momentum, constraints, and competitive strategies around the world from the region. The main drivers of the hydrazine hydrate market are the rising demand from agrochemicals industry, growing pharmaceutical sector and mounting demand for polymer foams.

The market is projected to grow because rising demand from agrochemicals industry. The agrochemicals industry offers substantial potential for the use of hydrazine hydrate for advancements in technologies and rapid developments in the manufacturing of agricultural products. Therefore, the rising demand from agrochemicals industry is a crucial driving factor behind the demand for hydrazine hydrate.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=172748863

Hydrazine Hydrate Companies

The key players in this market are Arkema S.A. (France), LANXESS AG (Germany), Lonza Group AG (Switzerland), LGC Science Group Holdings Limited (UK), and Nippon Carbide Industries Co., Inc. (Japan). The major market players given a high importance on incorporating new technologies to keep up with the frequently changing demands of the hydrazine hydrate around the world. To develop their market position in the industry, these players have implemented a range of growth strategies such as joint ventures, mergers & acquisitions, and launching new products. These strategies have been employed to expand their market share in the hydrazine hydrate industry.

Lanxess AG is a multinational manufacturer of specialty materials. Its main business is the development, manufacturing, and marketing of chemical intermediates, additives, and consumer protection products. The company offers hydrazine hydrate through its advanced industrial intermediate business unit. It operates 63 manufacturing sites in 19 countries and covers 33 countries in five regions. The company is improving its geographical presence, especially in the US, through acquisition.In August 2021, the company acquired Emerald Kalama Chemical. It is a US-based specialty chemicals manufacturing company. In General, this acquisition improved the value chain of the company in the consumer protection business segment.

Lonza Group AG is a multinational specialty chemical manufacturing company for the biotechnology, nutrition, and pharmaceutical sectors. It has became the world’s largest provider of water treatment products with its acquisition of Arch Chemicals in 2011. It offers hydrazine hydrate through its biologics business segment. Moreover, the company has a presence in Europe, North and Central America, Asia, Latin America, and Australia & New Zealand. Along with its presence, it has 37 manufacturing sites across the globe. In May 2022, the company made collaboration with ALSA Ventures. This collaboration is made to provide development and manufacturing services for biotech firms.

Get Sample Copy of this Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=172748863

Polymerization & Blowing Agents was the largest application of the hydrazine hydrate market, in terms of value, in 2021

Hydrazine hydrate is used in production plastics and rubber chemicals. It is used as a raw material foaming agents or chemical blowing agents. Also, the derivatives of hydrazine hydrates, such as azobis azodicarbonamide and isobutyronitrile, are used as low temperature blowing agents and polymerization initiators.

60%-85% is estimated to be the largest concentration level of the hydrazine hydrate, in terms of value, during the forecast period.

100%, 60%-85%, 40%-55% and 24%-35% are various market segment based on the concentration level. During the forecast period, 60%-85% is projected to hold the largest market share of hydrazine hydrate. This concentration level is used as a propellant in emergency power units (EPU) in the single-engine aircrafts, F16 fighter aircrafts. Moreover, it is also used in manufacturing of veterinary drugs, chemical synthesis and polymerization processes as initiator or blowing agent.

Asia Pacific is estimated to be the largest market for the hydrazine hydrate market, in terms of value, during the forecast period.

Asia Pacific is projected to be the largest market for hydrazine hydrate, both in terms of value and volume, during the forecast period. One of the major reasons for the growth of the hydrazine hydrate market in the Asia Pacific region is the increasing industrialization and economic development in countries within the region. In addition, less stringent regulations in the region helps manufacturers to produce and sell without any hindrance.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=172748863

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/hydrazine-hydrate-market-172748863.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hydrazine Hydrate Market Forecast 2022-2027: Global Size, Share, and Leading Players Revealed | Arkema S.A. (France), LANXESS AG (Germany), Lonza Group AG (Switzerland) & more

Niemann-Pick Disease Type C Therapeutics Market Size was ~USD 34 Million in 2022 and is anticipated to grow with a significant CAGR by 2034 | DelveInsight

DelveInsight’s “Niemann-Pick Disease Type C Drugs Market Insight, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of Niemann-Pick disease type C, historical and forecasted epidemiology as well as Niemann-Pick disease type C therapeutics market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

 

Unlock key insights into the Niemann-Pick Disease Type C Market! Download DelveInsight’s comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Niemann-Pick Disease Type C Market Size

 

Key Takeaways from the Niemann-Pick Disease Type C Market Report

  • The United States accounted for the highest number of Niemann-Pick disease type C Prevalent Cases in the 7MM in 2023.
  • Among gene-specific cases, Niemann-Pick disease type C1 accounted for most of the cases.
  • Among the gender-specific cases, Niemann-Pick disease type C1 affects males and females equally.
  • The leading Niemann-Pick Disease Type C Companies such as Mandos Health, Cycle Therapeutics, Intra Bio, Zevra Therapeutics, and others
  • Promising Niemann-Pick Disease Type C Therapies such as N-Acetyl-L-Leucine, Hydroxypropyl-beta-cyclodextrin, AZ-3102, and others.

 

Stay ahead in the competitive landscape of the Niemann-Pick Disease Type C Market. Access DelveInsight’s in-depth market analysis and strategic insights today! Click here for more @ Niemann-Pick Disease Type C Treatment Market Size

 

Niemann-Pick Disease Type C Epidemiology Segmentation in the 7MM

  • Total Diagnosed Prevalent cases
  • Gender- specific Diagnosed prevalent Cases
  • Distribution of diagnosed Prevalent Cases of Niemann-Pick disease Type C by age

 

Download the report to understand which factors are driving Niemann-Pick Disease Type C epidemiology trends @ Niemann-Pick Disease Type C Prevalence

 

Niemann-Pick Disease Type C Marketed Drugs

  • ZAVESCA/BRAZAVES (miglustat): Actelion Pharmaceuticals

ZAVESCA/BRAZAVES is a small iminosugar molecule that reversibly inhibits glycosphingolipid synthesis and blocks the synthesis of glycosphingolipids, one of the substances that accumulate in the brain of individuals with Niemann-Pick disease type C and can slow the progression of neurological symptoms associated with Niemann-Pick disease type C. It was approved by the EMA in 2009. It has been denied approval for the treatment of Niemann-Pick disease type C, by the US FDA on the grounds of insufficient data. However, it is being prescribed to the Niemann-Pick disease type C patients as an off-label therapy.

 

Emerging Niemann-Pick Disease Type C Drugs

  • Trappsol Cyclo: Cyclo Therapeutics

Trappsol by Cyclo Therapeutics is a proprietary formulation of hydroxypropyl betacyclodextrin and in multiple clinical studies has shown encouraging results to effectively manage the transportation of cholesterol. Taking the place of the defective Niemann-Pick disease type C protein, Trappsol Cyclo, with its cyclic structure, captures cholesterol within the cell and transports it out of the cell. The drug is currently being evaluated in Phase III TransportNPC pivotal trial in pediatric and adult patients with Niemann-Pick disease type C1. It has received an Orphan drug designation by the US FDA and the EMA. It has also received Rare Pediatric Disease Designation, and Fast-track designation by the US FDA for the treatment of Niemann-Pick disease type C.

 

  • IB10001: IntraBio

IntraBio’s lead drug series, IB1000s, is a set of orally administered, modified amino acids, N-acetyl-leucine, categorized by a well-established safety and tolerability profile. IB1001 (N-acetyl-l-leucine) is being developed for Niemann-Pick Disease Type C besides other orphan indications like Tay-Sachs and Sandhoff Disease, and inherited Cerebellar Ataxias. IB1000s have an effect on the normalization of neuronal membrane potential and intracellular ion regulation via calcium channels and have been observed to have symptomatic and neuroprotective properties and disease-modifying potential. The US FDA has accepted IntraBio’s NDA and granted priority review for IB1001 for the treatment of Niemann-Pick disease type C. The application has been granted Priority Review and a PDUFA target action date of September 24, 2024.

 

Discover the future of Niemann-Pick Disease Type C Treatments with DelveInsight’s latest market report. Get expert insights and forecasts—download now! @ Niemann-Pick Disease Type C Market Drivers and Barriers

 

Niemann-Pick Disease Type C Market Outlook

Various supportive therapies are available for managing symptoms linked with Niemann-Pick disease type C, including antiepileptics for seizures, tricyclic antidepressants, CNS stimulants for cataplexy, and anticholinergics for dystonia and tremor. However, these therapies contribute minimally to market revenue for Niemann-Pick disease type C1 treatment. ZAVESCA, prescribed to approximately half of Niemann-Pick disease type C patients, offers hope amidst the lack of disease-targeting therapies.

 

Scope of the Niemann-Pick Disease Type C Market Report

  • Coverage- 7MM
  • Study Period- 2020-2034
  • Niemann-Pick Disease Type C Companies- Mandos Health, Cycle Therapeutics, Intra Bio, Zevra Therapeutics, and others
  • Niemann-Pick Disease Type C Therapies- N-Acetyl-L-Leucine, Hydroxypropyl-beta-cyclodextrin, AZ-3102, and others.
  • Niemann-Pick Disease Type C Therapeutic Assessment: Niemann-Pick Disease Type C Current Marketed and Niemann-Pick Disease Type C Emerging Therapies
  • Niemann-Pick Disease Type C Market Dynamics: Niemann-Pick Disease Type C market drivers and Niemann-Pick Disease Type C market barriers
  • Niemann-Pick Disease Type C Unmet Needs, KOL’s views, Analyst’s views, Niemann-Pick Disease Type C Market Access and Reimbursement

 

Explore the dynamics of the Niemann-Pick Disease Type C Market with DelveInsight. From market size to emerging drugs—find it all in our latest report. Read now! @ Niemann-Pick Disease Type C Ongoing Clinical Trials Analysis

 

Table of Content

1. Key Insights

2. Report Introduction

3. Executive Summary

4. Niemann-Pick Disease Type C Market Overview at a Glance

5. Key Events

6. Epidemiology and Market Forecast Methodology

7. Disease Background and Overview

8. Niemann-Pick Disease Type C Epidemiology and Patient Population

9. Japan

10. Niemann-Pick Disease Type C Patient Journey

11. Niemann-Pick Disease Type C Marketed Drugs

12. Emerging Therapies

13. Niemann-Pick Disease Type C: Seven Major Market Analysis

14. Niemann-Pick Disease Type C Unmet Needs

15. SWOT Analysis

16. KOL Views

17. Reimbursement and Market Access

18. Appendix

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

 

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/catheter-stabilization-securement-device-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Niemann-Pick Disease Type C Therapeutics Market Size was ~USD 34 Million in 2022 and is anticipated to grow with a significant CAGR by 2034 | DelveInsight